INTELLI.B™

Features & Benefits

› Broad Coverage:

Comprehensive evaluation across multiple structural and functional attributes for fingerprint-like comparability

› Intelligent Database:

Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints

› Artificial Intelligence-Driven Data Analysis

› Glycan Profiling

› Predictive of Functional Activities:

  • Target binding
  • ADCC and CDC activity
  • Fc Receptor binding

Intelli.b™ – Biosimilar Fingerprinting Technology

Somru BioScience Inc. has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).

Application of Intelli.b™

Application of Intelli.b